Latest filing published 23 Feb 2023 for ImmunoPrecise Antibodies Ltd..
No signal scores available.
All filings by Lisa Anderson-Helbling on record concern ImmunoPrecise Antibodies Ltd. The record holds 3 filings, for trades running from 7 January 2019 to 13 December 2022.
Every open-market trade on record is a purchase: 1 purchase worth €1,570, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 23 February 2023, reports a transaction in ImmunoPrecise Antibodies Ltd. The clock since the last published purchase (13 November 2019) now reads 2,539 days. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations